MedTrace Logo

Clinical and Radiographic Outcomes of the JointMedica Polymotion Resurfacing (PHR) Device

NCT07080671 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-07-23

No results posted yet for this study

Summary

The goal of this observational study is to generate Real World Evidence (RWE) on the device performance of the Polymotion Hip Resurfacing (PHR) system and its use in patients who have been implanted with the device for the treatment of hip osteoarthritis.

This study will assess the following endpoints:

* The survivorship of the Acetabular Cup (Kaplan-Meier estimate) through 2 years of follow-up.
* Radiographic success of the implanted cups, through quantitative motion analysis to assess migration of the acetabular cups.
* Absence of subsequent surgical intervention at the acetabulum of there operated hip.
* Absence of serious, device-related adverse events.
* Patient reported outcomes through Harris Hip Score and SUSHI - UCLA Hip Score questionnaires.

Conditions

  • Healthy
  • Real World Data
  • Safety and Effectiveness
  • Patient Reported Outcome (PRO)

Sponsors & Collaborators

  • JointMedica Inc.

    lead OTHER

Principal Investigators

  • Ronan Treacy

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-25
Primary Completion
2026-10-31
Completion
2026-12-31

Countries

  • Australia
  • Canada
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07080671 on ClinicalTrials.gov